REQUEST A DEMO
Total
USD $0.00
Search more companies

Sls Bio Co. Ltd. (South Korea)

Main Activities: Medical and Diagnostic Laboratories
Full name: Sls Bio Co. Ltd. Profile Updated: June 25, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Sls Bio Co. Ltd. is an enterprise based in South Korea. Its main office is in Suwon. The company operates in the Medical and Diagnostic Laboratories sector. The company was established on May 13, 2026. Sls Bio Co. Ltd. currently employs 64 (2024) people. There was a net sales revenue drop of 44.32% reported in Sls Bio Co. Ltd.’s latest financial highlights for Q3C2025. Over the same period, its total assets decreased by 27.76%.

Headquarters
107,Gwanggyo-Ro, Yeongtong-Gu
Suwon; Gyeonggi;

Contact Details: Purchase the Sls Bio Co. Ltd. report to view the information.

Website: http://www.slabs.co.kr

Basic Information
Total Employees:
Purchase the Sls Bio Co. Ltd. report to view the information.
Outstanding Shares:
Purchase the Sls Bio Co. Ltd. report to view the information.
Financial Auditors:
Purchase the Sls Bio Co. Ltd. report to view the information.
Incorporation Date:
May 13, 2026
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Chief Technology Officer
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Director/Member of the Board
Subsidiaries
(주)에스엘에스바이오
Company Performance
Financial values in the chart are available after Sls Bio Co. Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
-44.32%
Total Operating Revenue
-44.37%
Operating Profit
N/A
EBITDA
N/A
Net Profit/Loss for the Period
N/A
Total Assets
-27.76%
Total Equity
-32.55%
Operating Profit Margin
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt / Equity
2.47%
Quick Ratio
-3.99%
Cash Ratio
-0.66%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?